CANY
ACAD icon

Caxton Associates (New York)’s Acadia Pharmaceuticals ACAD Stock Holding History

Caxton Associates (New York)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,972
Closed -$289K – 281
2020
Q2 		$289K Buy
+5,972
New +$289K 0.03% 256